OraSure Technologies | OSUR - Selling And Administration Expenses


OraSure Technologies reported $13.21M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 465M 11M Mar/2026
AngioDynamics USD 36.57M 3.79M Sep/2025
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Bio Techne USD 109.34M 4.35M Mar/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Bruker USD 238.9M 3.2M Jun/2026
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 228.9M 69.47M Jun/2026
Danaher USD 2.07B 212M Jun/2026
Dentsply International USD 364M 13M Jun/2026
Dexcom USD 358.7M 9M Jun/2026
Illumina USD 273M 1000K Jun/2026
Integra LifeSciences USD 166.22M 12.01M Jun/2026
Intuitive Surgical USD 617.9M 4.6M Jun/2026
IQVIA Holdings USD 574M 72M Jun/2026
Mesa Laboratories USD 27.31M 380K Sep/2024
Mettler Toledo International USD 263.33M 5.01M Jun/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quidel USD 189.7M 9.6M Jun/2026
Repligen USD 76.62M 82K Jun/2026
Revvity USD 278.58M 24.69M Jun/2026
STAAR Surgical USD 45.14M 6.5M Jun/2026
Thermo Fisher Scientific USD 1.91B 111M Jun/2026
Trinity Biotech USD 5.78M 405K Dec/2025
Waters USD 405M 11M Jun/2026